AL
AMAG

Airain Ltd’s AMAG Pharmaceuticals AMAG Stock Holding History

Airain Ltd’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-26,833
Closed -$605K – 1121
2017
Q1 		$605K Buy
+26,833
New +$642K 0.03% 447
2016
Q2 		– Sell
-32,195
Closed -$753K – 990
2016
Q1 		$753K Buy
+32,195
New +$764K 0.05% 353
2015
Q4 		– Sell
-30,905
Closed -$1.23M – 1129
2015
Q3 		$1.23M Buy
30,905
+9,570
+45% +$594K 0.07% 302
2015
Q2 		$1.47M Sell
21,335
-10,554
-33% -$664K 0.08% 272
2015
Q1 		$1.74M Buy
+31,889
New +$1.52M 0.11% 219
2014
Q1 		– Sell
-10,289
Closed -$250K – 910
2013
Q4 		$250K Buy
+10,289
New +$242K 0.03% 457

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Airain Ltd's AMAG Position: Q2 2017 in Review

Airain Ltd sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 26,833 shares — an estimated $605K sold.

Airain Ltd first reported a position in AMAG in Q4 2013 and held it in 6 quarters. The position peaked at $1.74M in Q1 2015. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Airain Ltd reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 26,833 AMAG Pharmaceuticals shares in Q2 2017, an estimated $605K.
  • Airain Ltd first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 6 quarters.
  • Airain Ltd's AMAG Pharmaceuticals position peaked at $1.74M in Q1 2015.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.